MCK: McKesson Corporation Stock

by  •  • Comments Off on MCK: McKesson Corporation Stock

SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries

Valuation
Market Cap ($M) 68,727.85
Enterprise Value ($M) 73,007.85
Book Value ($M) -1,682.00
Book Value / Share -12.80
Price / Book -40.86
NCAV ($M) -20,554.00
NCAV / Share -156.41
Price / NCAV -3.34

Profitability (mra)
Return on Invested Capital (ROIC) 0.51
Return on Assets (ROA) 0.05
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.50
Current Ratio 0.92

Balance Sheet (mrq) ($M)
Current Assets 47,640.00
Assets 66,512.00
Liabilities 68,194.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.13 -5.62
01-25 13G/A BlackRock Inc. 8.80 -1.01

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-09 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-15 44,014 272,556 16.15
2024-04-12 56,799 484,479 11.72
2024-04-11 53,438 486,267 10.99
2024-04-10 69,357 452,986 15.31

(click for more detail)

Similar Companies
CAH – Cardinal Health, Inc. HLF – Herbalife Ltd.
NUS – Nu Skin Enterprises, Inc.


Financial data and stock pages provided by
Fintel.io